Skip To The Main Content

FDA issues warning about Tigecycline

Oct 04, 2013

Medical Staff Colleague:

The FDA has added a new black box warning stating that there is now evidence of an increased risk of mortality with the use of Tigecycline (Tygacil) over other antibiotics, even when used for approved indications.  Please reserve the use of Tigecycline for situations only where alternative treatments are not suitable. 

Elliott R. Mandell, PhD, MBA, RPh
Vice President, Pharmacy
Tel:    210-297-4475
Cell:   210-315-1920